Clinical Trial Update: Optical Coherence Tomography (OCT) to Evaluate Cardiac Allograft Vasculopathy (CAV) in Patient's Post Heart Transplant

View source ↗

Summary

A completed clinical trial used Optical Coherence Tomography to evaluate cardiac allograft vasculopathy in patients after heart transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Allograft Vasculopathy

Snippet

Sponsor: Columbia University | Conditions: Cardiac Allograft Vasculopathy | Status: COMPLETED